<?xml version="1.0"?><?xml-stylesheet type="text/xsl" href="../../web/xslt/drug-table.xslt"?><drug name = "pamidronate inj VIAL">
<dose><value>90</value>
<value>30</value>
<value>60</value>
<value>0.5 - 1.5</value>
<value>0.5 - 1</value>
</dose><route><value>IV</value>
</route><form><value>inj VIAL</value>
</form><drugname><value>pamidronate inj VIAL</value>
</drugname><strength><value>3 mg/mL</value>
<value>6 mg/mL</value>
<value>9 mg/mL</value>
</strength><frequency><value>EVERY 3 WEEKS</value>
<value>EVERY 4 WEEKS</value>
<value>WEEKLY</value>
<value>ONCE</value>
<value>EVERY 2 WEEKS</value>
<value>DAILY</value>
</frequency><instruction><value>for 6 doses.</value>
<value>Administer as initial dose on week one.</value>
<value>for 3 doses.</value>
<value>for 3 days.</value>
</instruction><volume><value>10 mL</value>
</volume><units><value>mg</value>
<value>mg/kg/dose</value>
<value>mg/kg/day</value>
</units><additionalnotes><value>Regimen 1: Total dose = 180 mg.</value>
<value>Regimen 2: Total dose = 210 mg. (30 mg on week one, followed by 60 mg every 2 weeks for 3 doses.)</value>
<value>Retreatment regimen: Total dose = 180 mg. May be repeated every 6 months until; remission or relapse.</value>
<value>Maximum dose: 90 mg</value>
<value>Dose based upon initial plasma calcium levels, up to a Maximum dose of 90 mg.</value>
</additionalnotes><population><value>ADULT. Bone metastases in patients receiving chemotherapy.</value>
<value>ADULT. Bone metastases in patients NOT receiving chemotherapy.</value>
<value>ADULT. Multiple Myeloma</value>
<value>ADULT. Paget&amp;apos;s Disease</value>
<value>ADULT. Tumor-Induced Hypercalcemia (TIH)</value>
<value>INFANTS / CHILDREN. Hypercalcemia</value>
<value>INFANTS / CHILDREN. Osteogenesis Imperfecta</value>
</population><indicationprn></indicationprn><backgroundinformation><value>May repeat dose every 2 to 3 weeks as needed.</value>
<value>May repeat dose in 4 to 6 month intervals.</value>
</backgroundinformation><prninformation></prninformation><ahsformularystatus><value>Formulary.</value>
</ahsformularystatus><ahfsname><value>Bone Resorption Inhibitors</value>
</ahfsname><highalert></highalert><maximumprndose></maximumprndose><din><value>02244550</value>
</din><type><value>Medication/IV Therapy</value>
</type></drug>